Abstract
Purpose
It is unclear whether life-expectancy estimates of patients with advanced cancer and their caregivers are associated with patient existential, social, or emotional quality of life (QOL) or caregiver emotional QOL.
Methods
Patients with advanced cancer and their caregivers (n = 162 dyads) reported estimates of the chance the patient would live for 2 years or more from 0% (most pessimistic) to 100% (most optimistic). They also completed self-report measures of QOL.
Results
Adjusting for sociodemographic confounds and multiple comparisons, more pessimistic caregiver and patient life-expectancy estimates were associated with worse caregiver emotional QOL and worse patient existential QOL. Discrepancies between patient and caregiver estimates were not associated with patient or caregiver QOL.
Conclusions
Pessimistic life-expectancy estimates are associated with worse existential QOL in patients and worse emotional QOL in caregivers. Prospective research to establish causal relationships is needed, and interventions to address the relationship between beliefs about life expectancy and existential and emotional QOL should be considered. Providing these interventions to patients and caregivers receiving information on life expectancy may mitigate the negative impact of life-expectancy information on patient existential quality of life.
Similar content being viewed by others
References
Institute of Medicine of the National Academies (2008) Cancer care for the whole patient: Meeting psychosocial health needs. The National Academies Press, Washington, DC
Lechelt LA, Rieger JM, Cowan K, Debenham BJ, Krewski B, Nayar S, Regunathan A, Seikaly H, Singh AE, Laupacis A, on behalf of the Alberta Head and Neck Cancer Priority Setting Partnership Steering Committee (2018) Top 10 research priorities in head and neck cancer: results of an Alberta priority setting partnership of patients, caregivers, family members, and clinicians. Head Neck 40:544–554
Soni MK, Cella D (2002) Quality of life and symptom measures in oncology: an overview. Am J Manag Care 8:S560–S573
de Vries YC et al (2018) Taste and smell perception and quality of life during and after systemic therapy for breast cancer. Breast Cancer Res Treat 170:27–34
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK (2015) Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol 1:778–784
van Ryn M, Sanders S, Kahn K, van Houtven C, Griffin JM, Martin M, Atienza AA, Phelan S, Finstad D, Rowland J (2011) Objective burden, resources, and other stressors among informal cancer caregivers: a hidden quality issue? Psychooncology 20:44–52
National Alliance for Caregiving (2016) Cancer caregiving in the U.S.: An intense, episodic, and challenging care experience. http://www.caregiving.org/wp-content/uploads/2016/06/CancerCaregivingReport_FINAL_June-17-2016.pdf. Accessed 17 Oct 2016
Cooley ME, Nayak MM, Abrahm JL, Braun IM, Rabin MS, Brzozowski J, Lathan C, Berry DL (2017) Patient and caregiver perspectives on decision support for symptom and quality of life management during cancer treatment: implications for eHealth. Psychooncology 26:1105–1112
Jones SB, Whitford HS, Bond MJ (2015) Burden on informal caregivers of elderly cancer survivors: risk versus resilience. J Psychosoc Oncol 33:178–198
Cubukcu M (2018) Evaluation of quality of life in caregivers who are providing home care to cancer patients. Support Care Cancer 26:1457–1463
Mack JW, Weeks JC, Wright AA, Block SD, Prigerson HG (2010) End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 28:1203–1208
Trice ED et al (2009) Predictors of aggressive end-of-life care among Hispanic and white advanced cancer patients. J Clin Oncol 27:9538
El-Jawahri A et al (2014) Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer 120:278–285
Nipp RD, Greer JA, el-Jawahri A, Moran SM, Traeger L, Jacobs JM, Jacobsen JC, Gallagher ER, Park ER, Ryan DP, Jackson VA, Pirl WF, Temel JS (2017) Coping and prognostic awareness in patients with advanced cancer. J Clin Oncol 35:2551–2557
Victor A, George CE, Inbaraj LR, Norman G (2018) Benefit or harm? A study on impact of collusion on the quality of life among palliative care patients. Indian J Palliat Care 24:61–66
Hauksdottir A, Steineck G, Furst CJ, Valdimarsdottir U (2010) Long-term harm of low preparedness for a wife’s death from cancer--a population-based study of widowers 4-5 years after the loss. Am J Epidemiol 172:389–396
Tsai WI et al (2015) Longitudinal changes and predictors of prolonged grief for bereaved family caregivers over the first 2 years after the terminally ill cancer patient's death. Palliat Med 30:495–503
Epstein RM (2013) Whole mind and shared mind in clinical decision-making. Patient Educ Couns 90:200–206
Nipp RD, el-Jawahri A, Fishbein JN, Gallagher ER, Stagl JM, Park ER, Jackson VA, Pirl WF, Greer JA, Temel JS (2016) Factors associated with depression and anxiety symptoms in family caregivers of patients with incurable cancer. Ann Oncol 27:1607–1612
Yun YH, Kwon YC, Lee MK, Lee WJ, Jung KH, Do YR, Kim S, Heo DS, Choi JS, Park SY (2010) Experiences and attitudes of patients with terminal cancer and their family caregivers toward the disclosure of terminal illness. J Clin Oncol 28:1950–1957
Richardson AE, Morton RP, Broadbent EA (2016) Changes over time in head and neck cancer patients’ and caregivers’ illness perceptions and relationships with quality of life. Psychol Health 31:1203–1219
Hoerger M, Epstein RM, Winters PC, Fiscella K, Duberstein PR, Gramling R, Butow PN, Mohile SG, Kaesberg PR, Tang W, Plumb S, Walczak A, Back AL, Tancredi D, Venuti A, Cipri C, Escalera G, Ferro C, Gaudion D, Hoh B, Leatherwood B, Lewis L, Robinson M, Sullivan P, Kravitz RL (2013) Values and options in cancer care (VOICE): study design and rationale for a patient-centered communication and decision-making intervention for physicians, patients with advanced cancer, and their caregivers. BMC Cancer 13:188
Epstein RM, Duberstein PR, Fenton JJ, Fiscella K, Hoerger M, Tancredi DJ, Xing G, Gramling R, Mohile S, Franks P, Kaesberg P, Plumb S, Cipri CS, Street RL Jr, Shields CG, Back AL, Butow P, Walczak A, Tattersall M, Venuti A, Sullivan P, Robinson M, Hoh B, Lewis L, Kravitz RL (2017) Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncol 3:92–100
Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J, Dower J, Abraham J (2010) Prognostic significance of the “surprise” question in cancer patients. J Palliat Med 13:837–840
Downar J, Goldman R, Pinto R, Englesakis M, Adhikari NKJ (2017) The “surprise question” for predicting death in seriously ill patients: a systematic review and meta-analysis. Can Med Assoc J 189:E484–e493
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579
Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, Hackl NA, Heading G (2011) Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 22:2179–2190
Cohen SR et al (1997) Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 11:3–20
Cohen SR, Mount BM, Strobel MG, Bui F (1995) The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 9:207–219
Ware JE (2002) User’s manual for the SF-12v2 health survey (with a supplement documenting SF-12 health survey). QualityMetric Incorporated, Lincoln
Gramling R, Fiscella K, Xing G, Hoerger M, Duberstein P, Plumb S, Mohile S, Fenton JJ, Tancredi DJ, Kravitz RL, Epstein RM (2016) Determinants of patient-oncologist prognostic discordance in advanced cancer. JAMA Oncol 2:1421–1426
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742
Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33:1438–1445
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57:289–300
Breitbart W (2002) Spirituality and meaning in supportive care: spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. Support Care Cancer 10:272–280
Robinson S, Kissane DW, Brooker J, Burney S (2015) A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manag 49:595–610
Zhang AY, Siminoff LA (2003) Silence and cancer: why do families and patients fail to communicate? Health Commun 15:415–429
Alloy LB, Abramson LY (1979) Judgment of contingency in depressed and nondepressed students: sadder but wiser? J Exp Psychol Gen 108:441–485
Breitbart W, Rosenfeld B, Pessin H, Applebaum A, Kulikowski J, Lichtenthal WG (2015) Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol 33:749–754
Chochinov HM, Kristjanson LJ, Breitbart W, McClement S, Hack TF, Hassard T, Harlos M (2011) Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol 12:753–762
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Trevino, K.M., Maciejewski, P.K., Shen, M.J. et al. How much time is left? Associations between estimations of patient life expectancy and quality of life in patients and caregivers. Support Care Cancer 27, 2487–2496 (2019). https://doi.org/10.1007/s00520-018-4533-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4533-2